Afatinib 20 mg
$1,167.00
| Quantity Value | Price | Quantity | Add To Cart |
|---|---|---|---|
| 28 Tablets | $1,167.00 |
|
SKU : N/A
Category : Cancer
Afatinib 20 mg is an oral cancer medication containing the active ingredient Afatinib, used under medical supervision to treat EGFR mutation-positive non-small cell lung cancer.
Product Overview
Afatinib 20 mg is a prescription medication used in the management of certain types of cancer, particularly non-small cell lung cancer (NSCLC) with specific epidermal growth factor receptor (EGFR) mutations. It is designed to help slow the growth and spread of cancer cells by targeting abnormal signaling pathways that contribute to uncontrolled cell proliferation. Afatinib is recommended to be used strictly under medical supervision as part of a comprehensive treatment plan.
How It Works
Afatinib belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs). It works by irreversibly blocking the activity of the epidermal growth factor receptor (EGFR) family of proteins, which play a key role in the growth and division of cancer cells. By inhibiting these signaling pathways, Afatinib can reduce the rate of tumor growth and may improve clinical outcomes in patients with EGFR mutation-positive NSCLC. Its targeted mechanism makes it distinct from conventional chemotherapy, as it selectively affects cancer cells with the relevant receptor mutations.
Uses / Indications
Afatinib 20 mg is primarily indicated for the treatment of adult patients with:
-
Advanced or metastatic non-small cell lung cancer (NSCLC) harboring specific EGFR mutations.
-
Tumors that have demonstrated progression following other EGFR-targeted therapies (depending on clinical assessment).
The drug is not intended for general use outside these indications and should only be administered following a confirmed diagnosis and genetic testing to identify appropriate EGFR mutations.
Composition
Each tablet of Afatinib 20 mg contains:
-
Active ingredient: Afatinib (20 mg per tablet)
-
Excipients: Inactive ingredients that support tablet stability and absorption (commonly include lactose monohydrate, magnesium stearate, microcrystalline cellulose, among others).
Afatinib 20 mg is available in oral tablet form, making it convenient for patient-administered therapy while still requiring close medical oversight.
Administration
Afatinib 20 mg is administered orally, usually once daily, with or without food, as directed by a healthcare professional. Dosage and treatment schedules must be individualized based on the patient’s condition, tolerance, and laboratory monitoring. Continuous medical supervision is essential to manage potential side effects such as diarrhea, skin rash, or liver enzyme abnormalities, and to adjust dosing if necessary. Patients should follow their doctor’s instructions carefully and report any adverse reactions promptly.
Storage Instructions
-
Store Afatinib tablets in a cool, dry place, away from direct sunlight and moisture.
-
Keep the medication in its original container with the lid tightly closed.
-
Keep out of reach of children and pets.
-
Do not use after the expiration date printed on the package.
Important Information / Warnings
-
Afatinib 20 mg should only be used under the supervision of a qualified healthcare provider.
-
Regular monitoring of liver function, kidney function, and skin condition is recommended.
-
Patients should inform their doctor of any other medications, supplements, or medical conditions before starting therapy, as interactions may occur.
-
Pregnant or breastfeeding women should avoid use unless specifically advised by their physician.
-
Seek immediate medical attention for severe side effects such as persistent diarrhea, extreme fatigue, or signs of liver dysfunction.
For more detailed guidance on Afatinib therapy, patients can refer to the FDA official drug information page.
| Pack Size |
28 Tablets |
|---|
